<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2009-05-26" modified="2022-02-23" version="65">
<accession>A7X8C7</accession>
<name>PRGR_PAPAN</name>
<protein>
<recommendedName>
<fullName>Progesterone receptor</fullName>
<shortName>PR</shortName>
</recommendedName>
<alternativeName>
<fullName>Nuclear receptor subfamily 3 group C member 3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PGR</name>
<name type="synonym">NR3C3</name>
</gene>
<organism>
<name type="scientific">Papio anubis</name>
<name type="common">Olive baboon</name>
<dbReference type="NCBI Taxonomy" id="9555"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Cercopithecidae</taxon>
<taxon>Cercopithecinae</taxon>
<taxon>Papio</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2008" name="Mol. Phylogenet. Evol." volume="47" first="637" last="649">
<title>The human progesterone receptor shows evidence of adaptive evolution associated with its ability to act as a transcription factor.</title>
<authorList>
<person name="Chen C."/>
<person name="Opazo J.C."/>
<person name="Erez O."/>
<person name="Uddin M."/>
<person name="Santolaya-Forgas J."/>
<person name="Goodman M."/>
<person name="Grossman L.I."/>
<person name="Romero R."/>
<person name="Wildman D.E."/>
</authorList>
<dbReference type="PubMed" id="18375150"/>
<dbReference type="DOI" id="10.1016/j.ympev.2007.12.026"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<comment type="function">
<text evidence="2">The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation.</text>
</comment>
<comment type="subunit">
<text evidence="2 3">Interacts with SMARD1 and UNC45A. Interacts with CUEDC2; the interaction promotes ubiquitination, decreases sumoylation, and represses transcriptional activity. Interacts with PIAS3; the interaction promotes sumoylation of PR in a hormone-dependent manner, inhibits DNA-binding, and alters nuclear export. Interacts with SP1; the interaction requires ligand-induced phosphorylation on Ser-345 by ERK1/2-MAPK. Interacts with PRMT2. Interacts with NCOA2 and NCOA1. Interacts with KLF9. Interacts with GTF2B (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text evidence="1">Nucleoplasmic shuttling is both hormone- and cell cycle-dependent. On hormone stimulation, retained in the cytoplasm in the G(1) and G(2)/M phases (By similarity).</text>
</comment>
<comment type="domain">
<text>Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.</text>
</comment>
<comment type="PTM">
<text evidence="1">Phosphorylated on multiple serine sites. Several of these sites are hormone-dependent. Phosphorylation on Ser-294 is highly hormone-dependent and modulates ubiquitination and sumoylation on Lys-388. Phosphorylation on Ser-345 also requires induction by hormone. Basal phosphorylation on Ser-81, Ser-162, Ser-190 and Ser-400 is increased in response to progesterone and can be phosphorylated in vitro by the CDK2-A1 complex. Increased levels of phosphorylation on Ser-400 also in the presence of EGF, heregulin, IGF, PMA and FBS. Phosphorylation at this site by CDK2 is ligand-independent, and increases nuclear translocation and transcriptional activity. Phosphorylation at Ser-162 and Ser-294, but not at Ser-190, is impaired during the G(2)/M phase of the cell cycle. Phosphorylation on Ser-345 by ERK1/2 MAPK is required for interaction with SP1 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="1">Sumoylation is hormone-dependent and represses transcriptional activity. Sumoylation on all three sites is enhanced by PIAS3. Desumoylated by SENP1. Sumoylation on Lys-388, the main site of sumoylation, is repressed by ubiquitination on the same site, and modulated by phosphorylation at Ser-294 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="1">Ubiquitination is hormone-dependent and represses sumoylation on the same site. Promoted by MAPK-mediated phosphorylation on Ser-294 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="1">Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation (By similarity).</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the nuclear hormone receptor family.</text>
</comment>
<dbReference type="EMBL" id="DQ234986">
<property type="protein sequence ID" value="ABB72146.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001158062.1">
<property type="nucleotide sequence ID" value="NM_001164590.1"/>
</dbReference>
<dbReference type="SMR" id="A7X8C7"/>
<dbReference type="STRING" id="9555.ENSPANP00000010604"/>
<dbReference type="GeneID" id="100303420"/>
<dbReference type="CTD" id="5241"/>
<dbReference type="eggNOG" id="KOG3575">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="OrthoDB" id="615449at2759"/>
<dbReference type="Proteomes" id="UP000028761">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005496">
<property type="term" value="F:steroid binding"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003707">
<property type="term" value="F:steroid hormone receptor activity"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001723">
<property type="entry name" value="Nuclear_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000128">
<property type="entry name" value="Progest_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02161">
<property type="entry name" value="Prog_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00544">
<property type="entry name" value="PROGESTRONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00398">
<property type="entry name" value="STRDHORMONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="inferred from homology"/>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0754">Steroid-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Progesterone receptor" id="PRO_0000375859">
<location>
<begin position="1"/>
<end position="933"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="6">
<location>
<begin position="679"/>
<end position="913"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="5">
<location>
<begin position="567"/>
<end position="639"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="5">
<location>
<begin position="567"/>
<end position="587"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="5">
<location>
<begin position="603"/>
<end position="627"/>
</location>
</feature>
<feature type="region of interest" description="Modulating, Pro-Rich">
<location>
<begin position="1"/>
<end position="566"/>
</location>
</feature>
<feature type="region of interest" description="Disordered" evidence="7">
<location>
<begin position="1"/>
<end position="256"/>
</location>
</feature>
<feature type="region of interest" description="AF3; mediates transcriptional activation" evidence="2">
<location>
<begin position="1"/>
<end position="164"/>
</location>
</feature>
<feature type="region of interest" description="Mediates transcriptional transrepression" evidence="2">
<location>
<begin position="165"/>
<end position="305"/>
</location>
</feature>
<feature type="region of interest" description="Disordered" evidence="7">
<location>
<begin position="328"/>
<end position="380"/>
</location>
</feature>
<feature type="region of interest" description="Disordered" evidence="7">
<location>
<begin position="415"/>
<end position="452"/>
</location>
</feature>
<feature type="region of interest" description="AF1; mediates transcriptional activation" evidence="2">
<location>
<begin position="456"/>
<end position="546"/>
</location>
</feature>
<feature type="region of interest" description="AF2; mediates transcriptional activation" evidence="2">
<location>
<begin position="687"/>
<end position="933"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXL motif 1" evidence="2">
<location>
<begin position="55"/>
<end position="59"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXL motif 2" evidence="2">
<location>
<begin position="115"/>
<end position="119"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="4">
<location>
<begin position="183"/>
<end position="187"/>
</location>
</feature>
<feature type="compositionally biased region" description="Polar residues" evidence="7">
<location>
<begin position="70"/>
<end position="84"/>
</location>
</feature>
<feature type="compositionally biased region" description="Polar residues" evidence="7">
<location>
<begin position="120"/>
<end position="135"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro residues" evidence="7">
<location>
<begin position="415"/>
<end position="433"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="81"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="130"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="162"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="190"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="213"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1" evidence="2">
<location>
<position position="294"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK" evidence="2">
<location>
<position position="345"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2" evidence="2">
<location>
<position position="400"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="1">
<location>
<position position="388"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="2">
<location>
<position position="388"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="1">
<location>
<position position="531"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P06401"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q00175"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000256">
<source>
<dbReference type="SAM" id="MobiDB-lite"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000305"/>
<sequence length="933" mass="98950" checksum="349DB9E6B3ACFEDE" modified="2007-10-23" version="1">MTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFQGSQTSDTLPEVSAIPISLDGLLFPRPCQGQDPLDEKTQDQQSLSDVEGAYSRAEATRGTGGSSSRPPEKDSGLLHSVLDTLLAPSGPGQSQPSPPACEVTSSWCLFGPELPEDPPAAPATQGVLSPLMSRSGCKAGDSSGTAAAHKVLPRGLSPSRQLLLPASGSPHWSGAPVKPSPQPAAVEVEEEDGSESEESAGPLLKGKPRALGGAAAGGGAAAVPPGAAAGGVALVPKEDSRFSAPRVALVEQDAPMAPGRSPLATTTMDFTHVPILPLSHALLAARTRQLLEEESYDGGAGAASAFAPPRSSPSASSTPVAVGDFPDCAYPPDADPKDDAYPLYGDFQPPALKIKEEEEGAEVSARSPRSYLVAGANPAAFPDFPLGPPPPLPPRAPPSRPGEAAVTAAPAGASVSSASSSGSTLECILYKAEGAPPQQGPFAPPPCKAPGAGGCLLPRDGLPSTSASAAAAGAAPALYPALGLNGLPQLGYQAAVLKEGLQQVYPPYLNYLRPDSEASQSPQYSFESLPQKICLICGDEASGCHYGVLTCGSCKVFFKRAMEGQHNYLCAGRNDCIVDKIRRKNCPACRLRKCCQAGMVLGGRKFKKFNKVRVMRALDAVALPQPVGIPNESQALSQRFTFPPGQDIQLIPPLINLLVSIEPDVIYAGHDNSKPDTSSSLLTSLNQLGERQLLSVVKWSKLLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>